LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.

Dec 5, 2024 · Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. Includes Libtayo side effects, interactions and indications.

LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. [7] [8] Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway. [6] [9]

LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

LIBTAYO is a treatment that works by blocking PD-1, to stop binding with the cancer cell protein. The The T cell then remains active, so it can attack and kill the cancer cell.

Feb 23, 2021 · What is Libtayo? Libtayo is a prescription medicine used to treat people with: a type of skin cancer called cutaneous squamous cell carcinoma (CSCC). Libtayo may be used to treat CSCC that has spread or cannot be cured by surgery or radiation. a type of skin cancer called basal cell carcinoma (BCC). Libtayo may be used when your BCC:

LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

Oct 3, 2022 · Learn about side effects, uses, and more for Libtayo (cemiplimab-rwlc), which is a prescription drug that treats certain kinds of skin and lung cancer in adults.

Jun 13, 2023 · Libtayo (cemiplimab or cemiplimab-rwlc) is an immunotherapy medication that’s used to treat certain types of skin cancer and non-small cell lung cancer (NSCLC). It turns on your immune system to attack and kill cancer cells.